angiogenin and Hepatitis-B--Chronic

Persistent infections with hepatitis B virus (HBV) or hepatitis C virus (HCV) account for the majority of cases of hepatic cirrhosis and hepatocellular carcinoma (HCC) worldwide. Small, non-coding RNAs play important roles in virus-host interactions. We used high throughput sequencing to conduct an unbiased profiling of small (14-40 nts) RNAs in liver from Japanese subjects with advanced hepatitis B or C and hepatocellular carcinoma (HCC). Small RNAs derived from tRNAs, specifically 30-35 nucleotide-long 5' tRNA-halves (5' tRHs), were abundant in non-malignant liver and significantly increased in humans and chimpanzees with chronic viral hepatitis. 5' tRH abundance exceeded microRNA abundance in most infected non-cancerous tissues. In contrast, in matched cancer tissue, 5' tRH abundance was reduced, and relative abundance of individual 5' tRHs was altered. In hepatitis B-associated HCC, 5' tRH abundance correlated with expression of the tRNA-cleaving ribonuclease, angiogenin. These results demonstrate that tRHs are the most abundant small RNAs in chronically infected liver and that their abundance is altered in liver cancer.

Topics: Animals; Base Sequence; Carcinoma, Hepatocellular; Hepatitis B, Chronic; Hepatitis C, Chronic; High-Throughput Nucleotide Sequencing; Humans; Immunoprecipitation; Liver; Liver Neoplasms; MicroRNAs; Molecular Sequence Data; Pan troglodytes; Real-Time Polymerase Chain Reaction; Ribonuclease, Pancreatic; RNA, Transfer; Sequence Analysis, RNA